• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从体外多室传递系统中整合沉淀动力学和机制性口服吸收模型以预测弱碱性药物的药代动力学。

Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.

机构信息

Analytical Sciences, MRL, Merck & Co., Inc., Rahway, New Jersey 07065.

Biopharmaceutics & Specialty Dosage Form, MRL, Merck & Co., Inc., West Point, Pennsylvania 19486.

出版信息

J Pharm Sci. 2019 Jan;108(1):574-583. doi: 10.1016/j.xphs.2018.10.051. Epub 2018 Nov 3.

DOI:10.1016/j.xphs.2018.10.051
PMID:30395833
Abstract

Solubility, dissolution, and precipitation in the gastrointestinal tract can be critical for the oral bioavailability of weakly basic drugs. To understand the dissolution and precipitation during the transfer out of the stomach into the intestine, a multicompartment transfer system was developed by modifying a conventional dissolution system. This transfer system included gastric, intestinal, sink and supersaturation, and reservoir compartments. Simulated gastric fluid and fasted state simulated intestinal fluid were used in the gastric and intestinal compartment, respectively, to mimic fasted condition. The new transfer system was evaluated based on 2 model weak bases, dipyridamole and ketoconazole. Traditional 2-stage dissolution using 250 mL of simulated gastric fluid media, followed by 250 mL of fasted state simulated intestinal fluid, was used as a reference methodology to compare dissolution and precipitation results. An in silico model was built using R software suite to simulate the in vitro time-dependent dissolution and precipitation process when formulations were tested using the transfer system. The precipitation rate estimated from the in vitro data was then used as the input for absorption and pharmacokinetic predictions using GastroPlus. The resultant simulated plasma concentration profiles were generally in good agreement with the observed clinical data, supporting the translatability of the transfer system in vitro precipitation kinetics to in vivo.

摘要

在胃肠道中的溶解度、溶解和沉淀对于弱碱性药物的口服生物利用度可能至关重要。为了了解从胃转移到肠过程中的溶解和沉淀情况,通过对常规溶解系统进行修改,开发了一种多隔室传递系统。该传递系统包括胃、肠、吸收池和过饱和以及储库隔室。模拟胃液和空腹状态模拟肠液分别用于胃和肠隔室,以模拟空腹条件。该新的传递系统基于 2 种模型弱碱(双嘧达莫和酮康唑)进行了评估。使用 250 mL 模拟胃液介质的传统 2 阶段溶解,随后是 250 mL 空腹状态模拟肠液,作为参考方法用于比较溶解和沉淀结果。使用 R 软件套件构建了一个计算模型,以模拟在使用传递系统测试制剂时,体外时变溶解和沉淀过程。然后,将从体外数据估计的沉淀速率用作使用 GastroPlus 进行吸收和药代动力学预测的输入。所得模拟血浆浓度曲线通常与观察到的临床数据吻合良好,支持了传递系统在体外沉淀动力学向体内的可转化性。

相似文献

1
Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs.从体外多室传递系统中整合沉淀动力学和机制性口服吸收模型以预测弱碱性药物的药代动力学。
J Pharm Sci. 2019 Jan;108(1):574-583. doi: 10.1016/j.xphs.2018.10.051. Epub 2018 Nov 3.
2
The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).使用体内预测性溶出系统——胃肠道模拟器(GIS)研究过饱和水平对BCS IIb类药物双嘧达莫和酮康唑口服吸收的影响。
Eur J Pharm Sci. 2017 May 1;102:126-139. doi: 10.1016/j.ejps.2017.02.042. Epub 2017 Mar 3.
3
Utilization of Gastrointestinal Simulator, an in Vivo Predictive Dissolution Methodology, Coupled with Computational Approach To Forecast Oral Absorption of Dipyridamole.胃肠道模拟器的应用——一种体内预测性溶出方法,结合计算方法预测双嘧达莫的口服吸收情况。
Mol Pharm. 2017 Apr 3;14(4):1181-1189. doi: 10.1021/acs.molpharmaceut.6b01063. Epub 2017 Mar 3.
4
In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.计算机模拟方法评价泊沙康唑的胃肠道溶出度、过饱和度和沉淀。
Mol Pharm. 2017 Dec 4;14(12):4321-4333. doi: 10.1021/acs.molpharmaceut.7b00396. Epub 2017 Sep 5.
5
Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.基于模型的生物药剂学实验分析,以改善机制口服吸收建模:以酮康唑为模型药物的体外-体内外推综合视角。
Mol Pharm. 2017 Dec 4;14(12):4305-4320. doi: 10.1021/acs.molpharmaceut.7b00406. Epub 2017 Aug 25.
6
Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.桂利嗪口服吸收的预测——一种具有临界渗透性的高度过饱和难溶性弱碱。
Eur J Pharm Biopharm. 2014 Nov;88(3):795-806. doi: 10.1016/j.ejpb.2014.08.011. Epub 2014 Sep 6.
7
Simulation of Intraluminal Performance of Lipophilic Weak Bases in Fasted Healthy Adults Using DDDPlus.使用 DDDPlus 模拟脂溶性弱碱在健康禁食成人中的腔内性能。
AAPS J. 2022 Aug 16;24(5):89. doi: 10.1208/s12248-022-00737-7.
8
Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine.预测难溶性弱碱进入小肠后沉淀的情况。
J Pharm Pharmacol. 2004 Jan;56(1):43-51. doi: 10.1211/0022357022511.
9
Predicting the Changes in Oral Absorption of Weak Base Drugs Under Elevated Gastric pH Using an In Vitro-In Silico-In Vivo Approach: Case Examples-Dipyridamole, Prasugrel, and Nelfinavir.采用体外-计算机模拟-体内方法预测升高胃 pH 值条件下弱碱性药物口服吸收的变化:案例研究——双嘧达莫、普拉格雷和奈非那韦。
J Pharm Sci. 2019 Jan;108(1):584-591. doi: 10.1016/j.xphs.2018.11.008. Epub 2018 Nov 10.
10
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.体外溶出方法,微型胃肠道模拟器(mGIS),能更好地预测弱碱性药物达沙替尼的体内溶出情况。
Eur J Pharm Sci. 2015 Aug 30;76:203-12. doi: 10.1016/j.ejps.2015.05.013. Epub 2015 May 12.

引用本文的文献

1
Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of Dipyridamole Tablets.通过产品质量研究院(PQRI)联盟推进生物预测方法的协调一致:双嘧达莫片的生物预测溶出度。
Mol Pharm. 2024 Oct 7;21(10):5315-5325. doi: 10.1021/acs.molpharmaceut.4c00878. Epub 2024 Sep 23.
2
The Use of Global Sensitivity Analysis to Assess the Oral Absorption of Weakly Basic Compounds: A Case Example of Dipyridamole.应用全局敏感性分析评估弱碱性化合物的口服吸收:以双嘧达莫为例。
Pharm Res. 2024 May;41(5):877-890. doi: 10.1007/s11095-024-03688-0. Epub 2024 Mar 27.
3
Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration.
模型指导的药物研发:口服和经皮给药后药物生物性能的计算机模拟评估
Pharmaceuticals (Basel). 2024 Jan 30;17(2):177. doi: 10.3390/ph17020177.
4
Developing a Formulation Strategy Coupled with PBPK Modeling and Simulation for the Weakly Basic Drug Albendazole.为弱碱性药物阿苯达唑制定结合生理药代动力学(PBPK)建模与模拟的制剂策略。
Pharmaceutics. 2023 Mar 23;15(4):1040. doi: 10.3390/pharmaceutics15041040.
5
Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets.通过产品质量研究院(PQRI)协调生物预测方法学 第一部分:布洛芬和双嘧达莫片剂的生物预测溶出度。
AAPS J. 2023 Apr 21;25(3):45. doi: 10.1208/s12248-023-00793-7.
6
Integrating Forward and Reverse Translation in PBPK Modeling to Predict Food Effect on Oral Absorption of Weakly Basic Drugs.在生理药代动力学(PBPK)模型中整合正向和反向翻译以预测食物对弱碱性药物口服吸收的影响。
Pharm Res. 2023 Feb;40(2):405-418. doi: 10.1007/s11095-023-03478-0. Epub 2023 Feb 14.
7
Current State and Challenges of Physiologically Based Biopharmaceutics Modeling (PBBM) in Oral Drug Product Development.基于生理学的生物药剂学模型(PBBM)在口服药物产品开发中的现状与挑战
Pharm Res. 2023 Feb;40(2):321-336. doi: 10.1007/s11095-022-03373-0. Epub 2022 Sep 8.
8
Physiologically based Pharmacokinetic Models under the Prism of the Finite Absorption Time Concept.基于有限吸收时间概念视角下的生理药代动力学模型
Pharm Res. 2023 Feb;40(2):419-429. doi: 10.1007/s11095-022-03357-0. Epub 2022 Sep 1.